For research use only. Not for therapeutic Use.
Etigilimab (OMP-313M32), a humanized IgG1 monoclonal antibody, blocks TIGIT interaction with PVR (CD155; poliovirus receptor) and inhibits downstream signalling with target cell killing[1].
| Catalog Number | I040366 |
| CAS Number | 2044984-83-8 |
| Purity | ≥95% |
| Reference | [1]. Meredith McKean, et al. Safety and efficacy of etigilimab in combination with nivolumab in select recurrent/advanced solid tumors. |
